FdaApplication
ANDA 209450
Identifiers
- fda_app_no: ANDA209450
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2021-11-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LUBIPROSTONE | LUBIPROSTONE | 24MCG | CAPSULE;ORAL |
| LUBIPROSTONE | LUBIPROSTONE | 8MCG | CAPSULE;ORAL |
2 products